When Your Brain Won't Let Go: The Hidden Chemistry of Trauma and Recovery

When Your Brain Won't Let Go: The Hidden Chemistry of Trauma and Recovery

There's a particular cruelty to unresolved trauma—the way it loops. How a sound, a scent, or even just a Tuesday can pull you back into a moment you've been trying to leave behind for years. You tell yourself it's over. You remind yourself you're safe now. But your body doesn't seem to be listening. For a long time, we attributed this to willpower, to processing capacity, or to some vague notion of psychological strength. What we're learning now is that the difference between moving forward and staying stuck often comes down to dopamine—and specifically, to how your dopamine system interprets danger, reward, and safety in the aftermath of something terrible.

Dopamine has been painted as the pleasure chemical, the reward neurotransmitter that lights up when you eat chocolate or receive a compliment. But that framing misses something essential. Dopamine doesn't just make you feel good—it tells your brain what's worth your attention, what deserves effort, and critically, what you should do next when everything feels uncertain or dangerous (Willmore et al., 2022). When trauma strikes, your dopamine system doesn't shut down. It recalibrates. And depending on how it shifts, your brain might move toward adaptation or become trapped in a cycle of hypervigilance and fear. Recent research demonstrates that individuals who show resilience after trauma often have elevated dopamine activity in the nucleus accumbens during the stressful event itself, not afterward (Willmore et al., 2022; Cui et al., 2020). This timing matters profoundly. That surge of dopamine essentially increases the subjective value of the stressor, biasing the brain toward active coping rather than helplessness. It's the neurochemical foundation of agency—the difference between "this is unbearable" and "this is hard, but I can do something about it."

What happens when that dopamine response doesn't occur? The brain interprets the situation as insurmountable, and that interpretation becomes the scaffolding for susceptibility. This isn't a character flaw. It's a circuit-level phenomenon, shaped by genetics, early experiences, and the particular way your mesolimbic pathway has been wired and rewired over time (Baik, 2020). The mesolimbic dopamine pathway, which runs from the ventral tegmental area to the nucleus accumbens, is central to reward processing and motivation. When it functions adaptively, you feel capable of pursuing goals and staying engaged with life even when circumstances are difficult. But chronic stress can suppress this pathway, leading to what researchers call dopaminergic dysfunction—a state in which the reward system stops responding the way it should (Quessy et al., 2021). This is why trauma survivors often describe a pervasive sense of numbness or anhedonia, the inability to feel pleasure. It's not that they've chosen to disengage. Their dopamine system, which is supposed to signal that life is worth engaging with, has been flattened by the weight of unresolved stress.

One of the more elegant findings in this research involves something called the Rebound-Excitation Theory (Lee et al., 2016). During an acute fear response—say, a car accident or a violent encounter—dopamine neurons initially decrease their activity. The brain is focused on survival, not reward. But when the danger passes, those dopamine neurons don't just return to baseline. They spike. This rebound signal acts as an intrinsic safety cue, a neurochemical message that tells the fear circuits to stand down. For people with robust dopamine rebound responses, that signal helps terminate the fear response and allows the brain to transition from danger mode back into a state of relative calm. When that rebound doesn't happen, or when it's too weak to override the lingering activation in the amygdala, the fear circuit stays partially engaged. The brain never fully receives the memo that the threat has passed, and this is one of the core mechanisms underlying post-traumatic stress disorder (Lee et al., 2016). It's not about wanting to relive the trauma. It's that the dopamine system isn't delivering the signal that would allow the person to let it go.

This mismatch between cognitive understanding and neurochemical reality is what so many trauma survivors describe when they say, "I know I'm safe, but my body doesn't believe me." The prefrontal cortex—the part of the brain responsible for logic and reasoning—may recognize that the threat is over, but the amygdala continues firing because the dopamine rebound didn't do its job. Understanding this distinction can be profoundly relieving. It reframes the struggle not as a personal failure but as a failure of circuitry, one that can potentially be addressed through interventions that target dopamine function. Animal studies using optogenetic techniques have shown that artificially stimulating dopamine activity in the nucleus accumbens during stress can induce resilience-like behaviors, suggesting that dopamine isn't just a marker of resilience but an active driver of it (Willmore et al., 2022; Quessy et al., 2021). This opens the door to therapeutic strategies aimed at supporting or restoring dopaminergic function in trauma survivors.

Genetics also play a role, though not in the deterministic way people sometimes fear. Polymorphisms in dopamine-related genes—variations in receptors, transporters, and enzymes—do influence how the dopamine system responds to stress. Certain genetic variants are associated with increased vulnerability to PTSD, while others appear to confer some degree of protection (Tseilikman et al., 2022; Azadmarzabadi & Haghighatfard, 2021). But genes don't operate in isolation. They interact with environment and experience through epigenetic mechanisms, meaning that lived experiences can alter how genes are expressed. Early life adversity, for instance, can lead to epigenetic changes in dopamine receptor expression in regions like the hippocampus and prefrontal cortex, affecting how an individual processes stress and regulates emotions later in life (Köhler et al., 2018; Blum et al., 2019). Importantly, these epigenetic modifications aren't necessarily permanent. They can be modulated through new experiences, therapeutic intervention, and social connection. Genetics may set the stage, but they don't write the entire script.

There's also a crucial interplay between dopamine and other neurochemical systems, particularly norepinephrine. Noradrenergic input to dopamine neurons in the ventral tegmental area helps maintain the responsiveness and adaptability of the dopamine system under chronic stress (Isingrini et al., 2016; Zhang et al., 2019). When this regulatory relationship functions well, the dopamine system can stay balanced even in the face of prolonged adversity. When it's disrupted—as often happens with chronic trauma—the dopamine system can dysregulate, contributing to both the mood and cognitive symptoms seen in PTSD and depression. This highlights that trauma isn't about one system failing in isolation. It's about how multiple systems interact, or fail to interact, in ways that either support recovery or perpetuate suffering.

Perhaps one of the most striking findings involves dopamine neuron dormancy. Under conditions of extreme stress, dopamine neurons can enter a protective dormant state, reducing dopamine synthesis and increasing vesicular packaging to minimize cytotoxicity (Zuurbier et al., 2024). It's a survival mechanism—the brain prioritizing immediate survival over long-term function. In the short term, this makes sense. But when dopamine neurons remain dormant for extended periods, the result is the profound numbness and dissociation that characterizes severe trauma. Here's what's hopeful about this, though: dormancy isn't death. Dormant neurons can be reactivated when the environment becomes safer, when stress decreases, when support increases. Shutdown is protective, but it doesn't have to be permanent.

What does all of this mean for someone who's struggling? It means that resilience isn't a character trait you either possess or lack. It's neurobiological, rooted in dopamine function, which is influenced by a constellation of factors including genetics, early experiences, current environment, and the quality of connection and support available. Resilience can be cultivated, supported, and in many cases, restored. Interventions that enhance dopamine function—whether through exercise, which increases dopamine receptor expression and release in reward circuits, or through behavioral activation and social connection, which re-engage the dopamine system—can genuinely support recovery (Baik, 2020; Faye et al., 2018). This research also validates the experience of people who feel like their brains aren't working right after trauma. Because they're not imagining it. The dopamine system has been affected. Reward circuits have been disrupted. And having language for that can reduce the shame that so often accompanies post-traumatic symptoms.

What we're learning is that the brain has built-in resilience mechanisms, and dopamine is central to how those mechanisms function. Some brains navigate trauma more easily than others, and that's not a moral issue—it's biology. But biology can be influenced. It can be supported. It can heal. If you've been stuck in shutdown mode, if your brain has felt like it's been in hibernate, know that your dopamine system is more plastic than you might think. With intention, with support, with time, it can shift toward resilience. The work isn't about forcing yourself to feel better. It's about creating the conditions—neurochemically, relationally, environmentally—that allow your brain to remember that safety is possible.

Are you enjoying this topic? There is a podcast to goes more in depth!

References

Azadmarzabadi, E., & Haghighatfard, A. (2021). Detection of six novel de novo mutations in individuals with low resilience to psychological stress. PLoS ONE, 16, e0256285. https://doi.org/10.1371/journal.pone.0256285

Baik, J. (2020). Stress and the dopaminergic reward system. Experimental & Molecular Medicine, 52, 1879–1890. https://doi.org/10.1038/s12276-020-00532-4

Blum, K., Gondré-Lewis, M., Modestino, E., Lott, L., Baron, D., Siwicki, D., McLaughlin, T., Howeedy, A., Krengel, M., Oscar-Berman, M., Thanos, P., Elman, I., Hauser, M., Fried, L., Bowirrat, A., & Badgaiyan, R. (2019). Understanding the scientific basis of post-traumatic stress disorder (PTSD): Precision behavioral management overrides stigmatization. Molecular Neurobiology, 56, 7836–7850. https://doi.org/10.1007/s12035-019-1600-8

Cui, W., Aida, T., Ito, H., Kobayashi, K., Wada, Y., Kato, S., Nakano, T., Zhu, M., Isa, K., Kobayashi, K., Isa, T., Tanaka, K., & Aizawa, H. (2020). Dopaminergic signaling in the nucleus accumbens modulates stress-coping strategies during inescapable stress. The Journal of Neuroscience, 40, 7241–7254. https://doi.org/10.1523/jneurosci.0444-20.2020

Faye, C., McGowan, J., Denny, C., & David, D. (2018). Neurobiological mechanisms of stress resilience and implications for the aged population. Current Neuropharmacology, 16, 234–270. https://doi.org/10.2174/1570159x15666170818095105

Isingrini, E., Perret, L., Rainer, Q., Amilhon, B., Guma, E., Tanti, A., Martin, G., Robinson, J., Moquin, L., Marti, F., Mechawar, N., Williams, S., Gratton, A., & Giros, B. (2016). Resilience to chronic stress is mediated by noradrenergic regulation of dopamine neurons. Nature Neuroscience, 19, 560–563. https://doi.org/10.1038/nn.4245

Köhler, J., Gröger, N., Lesse, A., Ciurana, S., Rether, K., Fegert, J., Bock, J., & Braun, K. (2018). Early-life adversity induces epigenetically regulated changes in hippocampal dopaminergic molecular pathways. Molecular Neurobiology, 56, 3616–3625. https://doi.org/10.1007/s12035-018-1199-1

Lee, J., Wang, L., & Tsien, J. (2016). Dopamine rebound-excitation theory: Putting brakes on PTSD. Frontiers in Psychiatry, 7, 163. https://doi.org/10.3389/fpsyt.2016.00163

Quessy, F., Bittar, T., Blanchette, L., Lévesque, M., & Labonté, B. (2021). Stress-induced alterations of mesocortical and mesolimbic dopaminergic pathways. Scientific Reports, 11, 11000. https://doi.org/10.1038/s41598-021-90521-y

Tseilikman, V., Tseilikman, O., Pashkov, A., Ivleva, I., Karpenko, M., Shatilov, V., Zhukov, M., Fedotova, J., Kondashevskaya, M., Downey, H., & Manukhina, E. (2022). Mechanisms of susceptibility and resilience to PTSD: Role of dopamine metabolism and BDNF expression in the hippocampus. International Journal of Molecular Sciences, 23, 14575. https://doi.org/10.3390/ijms232314575

Willmore, L., Cameron, C., Yang, J., Witten, I., & Falkner, A. (2022). Behavioural and dopaminergic signatures of resilience. Nature, 611, 124–132. https://doi.org/10.1038/s41586-022-05328-2

Zhang, H., Chaudhury, D., Nectow, A., Friedman, A., Zhang, S., Juarez, B., Liu, H., Pfau, M., Aleyasin, H., Jiang, C., Crumiller, M., Calipari, E., Ku, S., Morel, C., Tzavaras, N., Montgomery, S., He, M., Salton, S., Russo, S., Nestler, E., Friedman, J., Cao, J., & Han, M. (2019). α1- and β3-adrenergic receptor–mediated mesolimbic homeostatic plasticity confers resilience to social stress in susceptible mice. Biological Psychiatry, 85, 226–236. https://doi.org/10.1016/j.biopsych.2018.08.020

Zuurbier, K., Fonseca, R., Arneaud, S., Wall, J., Kim, J., Tatge, L., Otuzoglu, G., Bali, S., Metang, P., & Douglas, P. (2024). Yin Yang 1 and guanine quadruplexes protect dopaminergic neurons from cellular stress via transmissive dormancy. Nature Communications, 15, 10508. https://doi.org/10.1038/s41467-024-54958-9